These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

297 related items for PubMed ID: 8822928

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. An antifibrinolytic mechanism describing the prothrombotic effect associated with factor VLeiden.
    Bajzar L, Kalafatis M, Simioni P, Tracy PB.
    J Biol Chem; 1996 Sep 20; 271(38):22949-52. PubMed ID: 8798478
    [Abstract] [Full Text] [Related]

  • 3. Both cellular and soluble forms of thrombomodulin inhibit fibrinolysis by potentiating the activation of thrombin-activable fibrinolysis inhibitor.
    Bajzar L, Nesheim M, Morser J, Tracy PB.
    J Biol Chem; 1998 Jan 30; 273(5):2792-8. PubMed ID: 9446587
    [Abstract] [Full Text] [Related]

  • 4. Thrombin-activatable fibrinolysis inhibitor antigen and TAFI activity in patients with APC resistance caused by factor V Leiden mutation.
    Antovic JP, Blombäck M.
    Thromb Res; 2002 Apr 01; 106(1):59-62. PubMed ID: 12165290
    [Abstract] [Full Text] [Related]

  • 5. Purification and characterization of TAFI, a thrombin-activable fibrinolysis inhibitor.
    Bajzar L, Manuel R, Nesheim ME.
    J Biol Chem; 1995 Jun 16; 270(24):14477-84. PubMed ID: 7782309
    [Abstract] [Full Text] [Related]

  • 6. Thrombin, thrombomodulin and TAFI in the molecular link between coagulation and fibrinolysis.
    Nesheim M, Wang W, Boffa M, Nagashima M, Morser J, Bajzar L.
    Thromb Haemost; 1997 Jul 16; 78(1):386-91. PubMed ID: 9198184
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Demonstration of enhanced endogenous fibrinolysis in thrombin activatable fibrinolysis inhibitor-deficient mice.
    Mao SS, Holahan MA, Bailey C, Wu G, Colussi D, Carroll SS, Cook JJ.
    Blood Coagul Fibrinolysis; 2005 Sep 16; 16(6):407-15. PubMed ID: 16093731
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Reduced fibrinolytic resistance in patients with factor XI deficiency. Evidence of a thrombin-independent impairment of the thrombin-activatable fibrinolysis inhibitor pathway.
    Colucci M, Incampo F, Cannavò A, Menegatti M, Siboni SM, Zaccaria F, Semeraro N, Peyvandi F.
    J Thromb Haemost; 2016 Aug 16; 14(8):1603-14. PubMed ID: 27094709
    [Abstract] [Full Text] [Related]

  • 13. Thrombin activatable fibrinolysis inhibitor (TAFI) does not inhibit in vitro thrombolysis by pharmacological concentrations of t-PA.
    Colucci M, D'Aprile AM, Italia A, Gresele P, Morser J, Semeraro N.
    Thromb Haemost; 2001 Apr 16; 85(4):661-6. PubMed ID: 11341502
    [Abstract] [Full Text] [Related]

  • 14. Dabigatran enhances clot susceptibility to fibrinolysis by mechanisms dependent on and independent of thrombin-activatable fibrinolysis inhibitor.
    Ammollo CT, Semeraro F, Incampo F, Semeraro N, Colucci M.
    J Thromb Haemost; 2010 Apr 16; 8(4):790-8. PubMed ID: 20088944
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Thrombin-mediated activation of factor XI results in a thrombin-activatable fibrinolysis inhibitor-dependent inhibition of fibrinolysis.
    Von dem Borne PA, Bajzar L, Meijers JC, Nesheim ME, Bouma BN.
    J Clin Invest; 1997 May 15; 99(10):2323-7. PubMed ID: 9153272
    [Abstract] [Full Text] [Related]

  • 17. Thrombin-activable fibrinolysis inhibitor zymogen does not play a significant role in the attenuation of fibrinolysis.
    Foley JH, Kim P, Nesheim ME.
    J Biol Chem; 2008 Apr 04; 283(14):8863-7. PubMed ID: 18252711
    [Abstract] [Full Text] [Related]

  • 18. The impact of the endothelial protein C receptor on thrombin generation and clot lysis.
    Pepler L, Wu C, Dwivedi DJ, Wu C, Kim PY, Liaw PC.
    Thromb Res; 2017 Apr 04; 152():30-37. PubMed ID: 28219843
    [Abstract] [Full Text] [Related]

  • 19. Tissue factor-expressing monocytes inhibit fibrinolysis through a TAFI-mediated mechanism, and make clots resistant to heparins.
    Semeraro F, Ammollo CT, Semeraro N, Colucci M.
    Haematologica; 2009 Jun 04; 94(6):819-26. PubMed ID: 19377079
    [Abstract] [Full Text] [Related]

  • 20. The intrinsic threshold of the fibrinolytic system is modulated by basic carboxypeptidases, but the magnitude of the antifibrinolytic effect of activated thrombin-activable fibrinolysis inhibitor is masked by its instability.
    Walker JB, Bajzar L.
    J Biol Chem; 2004 Jul 02; 279(27):27896-904. PubMed ID: 15128744
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.